Machine learning risk stratification strategy for multiple myeloma: Insights from the EMN-HARMONY Alliance platform [0.03%]
机器学习风险分层策略在多发性骨髓瘤中的应用：EMN-HARMONY联盟平台的见解
Adrian Mosquera Orgueira,Marta Sonia Gonzalez Perez,Mattia D&#x;Agostino et al.
Adrian Mosquera Orgueira et al.
Traditional risk stratification in multiple myeloma (MM) relies on clinical and cytogenetic parameters but has limited predictive accuracy. Machine learning (ML) offers a novel approach by leveraging large datasets and complex variable inte...
Correction to "Comparing functional and genomic-based precision medicine in blood cancer patients" [0.03%]
Correction to "基于功能和基因组的精确诊疗在血液癌症患者中的比较"
[This corrects the article DOI: 10.1002/hem3.70129.]. © 2025 The Author(s). HemaSphere published by John Wiley & Sons Ltd on behalf of European Hematolo...
Published Erratum
HemaSphere. 2025 Oct 8;9(10):e70220. DOI:10.1002/hem3.70220 2025
Towards personalized medicine for refractory/relapsed follicular lymphoma patients: The Lupiae-Cantera study [0.03%]
复发及难治性滤泡淋巴瘤患者个性化治疗研究——Lupiae-Cantera研究
Irene Dogliotti,Sanne Tonino,Luana Conte et al.
Irene Dogliotti et al.
Editorial
HemaSphere. 2025 Oct 8;9(10):e70230. DOI:10.1002/hem3.70230 2025
Independent confirmation of the immunophenotypic ELN Scoring System in patients with MDS and CMML [0.03%]
MDS和CMML患者中独立确认免疫表型ELN评分系统的有效性
Uta Oelschlaegel,Jonas Schadt,Katharina Epp et al.
Uta Oelschlaegel et al.
Strengthening awareness and response to HTLV-1 infection in Africa: A neglected threat to blood safety and public health [0.03%]
提高非洲国家对人类T细胞白血病病毒Ⅰ型感染的意识和应对能力：一个威胁血液安全和公共健康的被忽视的问题
Jean-Claude Twizere,Carolina Rosadas,Maureen Kidiga et al.
Jean-Claude Twizere et al.
Medical haematology trial eligibility and the Duffy null-associated neutrophil count: A cross-sectional study [0.03%]
与杜飞等位基因缺失相关的中性粒细胞计数和医学血液学试验的资格：横断面研究
Olga Tsiamita,Laura Aiken,Mohsin Badat et al.
Olga Tsiamita et al.
Immune signatures in older patients with newly diagnosed multiple myeloma are associated with survival outcomes of first-line therapy irrespective of frailty levels [0.03%]
新诊断的多发性骨髓瘤老年患者的免疫特征与脆弱程度独立的一线治疗预后有关
Wassilis S C Bruins,Febe Smits,Carolien Duetz et al.
Wassilis S C Bruins et al.
The treatment landscape for older patients with multiple myeloma (MM) has rapidly evolved with the introduction of CD38-targeting antibodies. Yet, outcomes remain highly variable and are only partially explained by frailty status. To addres...
Patterns of immune recovery after axicabtagene ciloleucel for aggressive B-cell lymphoma [0.03%]
阿基珠单抗治疗侵袭性B细胞淋巴瘤后免疫重建的模式
André Airosa Pardal,Ana Benzaquén,Pablo Granados et al.
André Airosa Pardal et al.
Hematotoxicity after anti-CD19 chimeric antigen receptor T-cell therapy has drawn attention for potential long-term effects, and yet, recovery of lymphocyte subsets and immunoglobulin levels beyond B-cell aplasia remains poorly understood. ...
Transcriptome profiling of megakaryocytes and platelets: Application to GP9- and IKZF5-related thrombocytopenia [0.03%]
巨核细胞和血小板转录组特征分析及其在GP9和IKZF5相关血小板减少症中的应用
Koenraad De Wispelaere,Fabienne Ver Donck,Kato Ramaekers et al.
Koenraad De Wispelaere et al.
Platelets are anucleate cells produced in the bone marrow and derived from large progenitor cells called megakaryocytes (MKs). Platelets receive RNA transcripts from their progenitorial MKs during thrombopoiesis. However, the correspondence...
Xq24/ IL13RA1 aberrations as key drivers of female bias in primary mediastinal large B-cell lymphoma [0.03%]
原发纵隔大B细胞淋巴瘤中XQ24 / IL13RA1异常导致女性易感性的关键驱动因素
Lukas Marcelis,Ryan Nicolaas Allsop,Marlies Vanden Bempt et al.
Lukas Marcelis et al.
Female-biased incidence in primary mediastinal large B-cell lymphoma (PMBCL) is enigmatic and points to a potential contribution of the X chromosome in this disease. To elucidate the postulated involvement of X-linked factor(s), we profiled...